SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-15-337608
Filing Date
2015-10-05
Accepted
2015-10-05 17:20:11
Documents
4
Group Members
BLUE SUBSIDIARY CORP.VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A AMEND#5 d80971dsctota.htm SC TO-T/A 37086
2 EX-(A)(5)(F) d80971dex99a5f.htm EX-99.(A)(5)(F) 8565
3 GRAPHIC g80971g19x72.jpg GRAPHIC 3005
4 GRAPHIC g80971g77d45.jpg GRAPHIC 1547
  Complete submission text file 0001193125-15-337608.txt   54172
Mailing Address 3845 CORPORATE CENTRE DRIVE O'FALLON MO 63368
Business Address 3845 CORPORATE CENTRE DRIVE O'FALLON MO 63368 636-939-5100
SYNERGETICS USA INC (Subject) CIK: 0000836429 (see all company filings)

IRS No.: 205715943 | Fiscal Year End: 0731
Type: SC TO-T/A | Act: 34 | File No.: 005-44538 | Film No.: 151144188
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations